Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Trial Shows Antibody Effective Against Asthma

Results from a large-scale clinical trial show a synthetic antibody, when added to standard treatments, reduces asthma attacks and improves lung functioning. . . . → Read More: Trial Shows Antibody Effective Against Asthma

NIH Funds Heart Tissue Regeneration Tests in Pigs

An experimental drug to help grow new heart tissue after a heart attack is advancing to tests in pigs, with help from National Institutes of Health. . . . → Read More: NIH Funds Heart Tissue Regeneration Tests in Pigs

Phone App Found to Measure Heart Health Metrics

A medical engineering team designed a smartphone app that in a clinical study shows it can measure key factors in heart health as accurately as MRI scans. . . . → Read More: Phone App Found to Measure Heart Health Metrics

Engineered T-Cell Trials Stopped after Patient Death

The Food and Drug Administration stopped two clinical trials testing genetically engineered T-cells from the immune system to treat leukemia, after a participant in one trial died. . . . → Read More: Engineered T-Cell Trials Stopped after Patient Death

Trial Underway Testing Alzheimer’s-Schizophrenia Drug

A new clinical trial began in the U.K. in a test of an experimental drug to treat schizophrenia associated with Alzheimer’s disease. . . . → Read More: Trial Underway Testing Alzheimer’s-Schizophrenia Drug

Trial Shows Smartphone App Finds More Heart Disease

Results from a clinical trial show an electrocardiogram app on a smartphone detects more cases of irregular heart beats than routine office visits. . . . → Read More: Trial Shows Smartphone App Finds More Heart Disease

Trial Testing Nicotine Patch for Lung Inflammation

A clinical trial is underway testing a nicotine patch worn to help stop smoking as a treatment for a chronic inflammatory disease affecting the lungs. . . . → Read More: Trial Testing Nicotine Patch for Lung Inflammation

Engineered T-Cell Company Acquired for $11.9 Billion

A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion. . . . → Read More: Engineered T-Cell Company Acquired for $11.9 Billion

Clinical Trial Okayed for Parkinson’s Drug Implant

A maker of implants for long-term release of drugs to treat chronic diseases says the Food and Drug Administration approved a clinical trial to test its implant for Parkinson’s disease. . . . → Read More: Clinical Trial Okayed for Parkinson’s Drug Implant

Telemedicine Shown Feasible for Parkinson’s Care

Findings from a one-year clinical trial show individuals in the U.S. with Parkinson’s disease can receive quality care through telemedicine comparable to persons with the disorder receiving the usual care from neurologists alone. . . . → Read More: Telemedicine Shown Feasible for Parkinson’s Care